Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB26FPPA3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,143
Award facts
- Contract value 100% obligated
- $15,143.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $15,143.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nucala 100 mg/ml auto-injectors. The delivery order, awarded on October 17, 2025, with an ultimate completion date of October 20, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is the sole awardee with no identified subcontractors on this transaction.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceutical products and medical consumables to military healthcare facilities worldwide. The underlying indefinite delivery contract, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables to support the Department of Defense's recurring medical supply needs globally. The contractor's extensive product portfolio and demonstrated performance across multiple therapeutic categories position it as a critical pharmaceutical supplier within the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FPPA3?
SPE2DB26FPPA3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FPPA3 worth?
The government has obligated $15,143 on SPE2DB26FPPA3.
Is contract SPE2DB26FPPA3 an order under another contract?
Yes. SPE2DB26FPPA3 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB26FPPA3 competed?
The extent of competition for SPE2DB26FPPA3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award